Loading...
Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: A highly potent orally available CCR5 selective antagonist
Based on the original spirodiketopiperazine design framework, further optimization of an orally available CCR5 antagonist was undertaken. Structural hybridization of the hydroxylated analog 4 derived from one of the oxidative metabolites and the new orally available non-hydroxylated benzoic acid ana...
Na minha lista:
| Udgivet i: | Bioorg Med Chem |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604827/ https://ncbi.nlm.nih.gov/pubmed/21658961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2011.05.022 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|